Gentel Biosurfaces Changes Name to Gentel Biosciences
News Jan 13, 2006
GenTel BioSurfaces, Inc. has announced that it has changed its name to GenTel BioSciences, Inc.
"We have become more than a surface chemistry company," says Alex Vodenlich, President and CEO.
"The name change reflects our company’s growth into an integrated, full-service multiplex immunoassay company."
"GenTel’s core business centers on providing cutting-edge biochip products and services to the life science research and drug discovery communities," explains Vodenlich.
Nonalcoholic fatty liver disease produces no noticeable symptoms, but one out of every five people with it will go on to develop a more serious conditions such as nonalcoholic steatohepatosis and cirrhosis. Three new studies investigate how mitochondrial energy production is altered by the progress of fatty liver disease.READ MORE